Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals

被引:83
作者
Ishizaka, N
Ishizaka, Y
Toda, EI
Hashimoto, H
Nagai, R
Yamakado, M
机构
[1] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan
[2] Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Tokyo, Japan
[3] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo, Japan
关键词
carotid arteriosclerosis; smoking status; metabolic syndrome; insulin resistance;
D O I
10.1016/j.atherosclerosis.2005.01.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cigarette smoking is associated with increased insulin resistance and other metabolic abnormalities. Here, we investigate the prevalence of metabolic syndrome (MetS) in cigarette smokers and people who never smoked by analyzing cross-sectional data of 5033 subjects aged between 35 and 65 years who underwent general health screening. Both former and current smoking was associated with an increased incidence of metabolic syndrome defined by modified-National Cholesterol Education Program (NCEP) criteria with odds ratios of 1.77 (9517o CI 1.42-2.22, P < 0.0001) and 2.38 (95% CI 1.95-2.91, P < 0.0001), respectively. In both former and current smokers, prevalence of metabolic syndrome increased when the duration of cigarette smoking was >= 10 years. The positive association between metabolic syndrome and smoking was only partially reversed even 5 years after quitting. Multivariate logistic regression analysis showed that metabolic syndrome was an independent risk factor for carotid plaque with an odds ratio of 1.72 (95% CI 1.43-2.08, P < 0.0001). On the other hand, when limited to individuals without metabolic syndrome, former and current smoking was still found to be associated with carotid plaque with odds ratios of 1.49 (95% CI 1.15-1.92, P = 0.0023) and 1.57 (95% CI 1.22-2.03, P = 0.0005), respectively, in men. Collectively, these data suggest that the atherogenic consequences of smoking may, at least in part, be explained by its association with metabolic syndrome. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 30 条
  • [1] The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
    Bonora, E
    Targher, G
    Formentini, G
    Calcaterra, F
    Lombardi, S
    Marini, F
    Zenari, L
    Saggiani, F
    Poli, M
    Perbellini, S
    Raffaelli, A
    Gemma, L
    Santi, L
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETIC MEDICINE, 2004, 21 (01) : 52 - 58
  • [2] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [3] Association between smoking, insulin resistance and β-cell function in a North-western First Nation
    Daniel, M
    Cargo, MD
    [J]. DIABETIC MEDICINE, 2004, 21 (02) : 188 - 193
  • [4] Tumor necrosis factor α produces insulin resistance in skeletal muscle by activation of inhibitor κB kinase in a p38 MAPK-dependent manner
    de Alvaro, C
    Teruel, T
    Hernandez, R
    Lorenzo, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (17) : 17070 - 17078
  • [5] Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x
  • [6] Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity
    Dobrian, AD
    Schriver, SD
    Khraibi, AA
    Prewitt, RL
    [J]. HYPERTENSION, 2004, 43 (01) : 48 - 56
  • [7] The metabolic syndrome as a link between smoking and cardiovascular disease
    Dzien, A
    Dzien-Bischinger, C
    Hoppichler, F
    Lechleitner, M
    [J]. DIABETES OBESITY & METABOLISM, 2004, 6 (02) : 127 - 132
  • [8] INSULIN RESISTANCE AND CIGARETTE-SMOKING
    FACCHINI, FS
    HOLLENBECK, CB
    JEPPESEN, J
    CHEN, YDI
    REAVEN, GM
    [J]. LANCET, 1992, 339 (8802) : 1128 - 1130
  • [9] Management of Co-existing diabetes mellitus and dyslipidemia: Defining the role of thiazolidinediones
    Florkowski C.M.
    [J]. American Journal of Cardiovascular Drugs, 2002, 2 (1) : 15 - 21
  • [10] Effect of the thiazolidinediones on cardiovascular risk factors
    Gilling L.
    Suwattee P.
    DeSouza C.
    Asnani S.
    Fonseca V.
    [J]. American Journal of Cardiovascular Drugs, 2002, 2 (3) : 149 - 156